Diffuse liver disease: Strategies for hepatic CT and MR imaging

Radiographics

Volumn 29, Issue 6, 2009, Pages 1591-1614

  Bol, Daniel T ^a   Merkle, Elmar M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER DISEASE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY;

HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77449127465     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.296095513     Document Type: Article

References (50)

1. Kamel IR, Kruskal JB, Pomfret EA, Keogan MT, Warmbrand G, Raptopoulos V. Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation. AJR Am J Roentgenol 2001;176:193-200.
2. Flohr TG, McCollough CH, Bruder H, et al. First performance evaluation of a dual-source CT (DSCT) system. Eur Radiol 2006;16:256-268.
3. Dwyer A, Doppman JL, Adams AJ, Girton ME, Chernick SS, Cornblath M. Influence of glycogen on liver density: computed tomography from a metabolic perspective. J Comput Assist Tomogr 1983;7:70-73.
4. Awai K, Inoue M, Yagyu Y, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 2004; 233:682-688.
5. Goshima S, Kanematsu M, Kondo H, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol 2006;187:W25-W32.
6. Boll DT, Merkle EM, Paulson EK, Fleiter TR. Coronary stent patency: dual-energy multidetector CT assessment in a pilot study with anthropomorphic phantom. Radiology 2008;247:687-695.
7. Nakayama Y, Awai K, Funama Y, et al. Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology 2005;237:945-951.
8. Khalili K, Lan FP, Hanbidge AE, Muradali D, Oreopoulos DG, Wanless IR. Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence. AJR Am J Roentgenol 2003;180:1601-1604.
9. Van Lom KJ, Brown JJ, Perman WH, Sandstrom JC, Lee JK. Liver imaging at 1.5 tesla: pulse sequence optimization based on improved measurement of tissue relaxation times. Magn Reson Imaging 1991;9:165-171.
10. Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med 1997;38:591-603.
11. Schindera ST, Soher BJ, Delong DM, Dale BM, Merkle EM. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology 2008;248: 140-147.
12. Tsurusaki M, Semelka RC, Zapparoli M, et al. Quantitative and qualitative comparison of 3.0T and 1.5T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 2008 Sep 12. [Epub ahead of print]
13. Hori M, Murakami T, Kim T, et al. Single breathhold T2-weighted MR imaging of the liver: value of single-shot fast spin-echo and multishot spinecho echoplanar imaging. AJR Am J Roentgenol 2000;174:1423-1431.
14. Boll DT, Merkle EM, Seaman DM, et al. Comparison of ECG-gated rectilinear vs. real-time radial K-space sampling schemes in cine True-FISP cardiac MRI. J Cardiovasc Magn Reson 2004;6: 793-802.
15. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-485.
16. Hernandez-Guerra M, Garcia-Pagan JC, Bosch J. Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J Clin Gastroenterol 2005;39:S131-S137.
17. Ganne-Carrié N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-1517.
18. Talwalkar JA, Yin M, Fidler JL, Sanderson SO, Kamath PS, Ehman RL. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 2008;47:332-342.
19. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5:1207-1213.
20. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
21. Coffin CM, Diche T, Mahfouz A, et al. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 1999;9:444-449.
22. Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of superparamagnetic iron oxideenhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 2004;182:1217-1223.
23. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
24. Vogt FM, Antoch G, Hunold P, et al. Parallel acquisition techniques for accelerated volumetric interpolated breath-hold examination magnetic resonance imaging of the upper abdomen: assessment of image quality and lesion conspicuity. J Magn Reson Imaging 2005;21:376-382.
25. Kim YK, Kim CS, Kwak HS, Lee JM. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced MR imaging. J Magn Reson Imaging 2004;20:826-837.
26. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129:113-121.
27. Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999;19:221-229.
28. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.
29. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis 2004;24:3-20.
30. Raptopoulos V, Karellas A, Bernstein J, Reale FR, Constantinou C, Zawacki JK. Value of dual-energy CT in differentiating focal fatty infiltration of the liver from low-density masses. AJR Am J Roentgenol 1991;157:721-725.
31. Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 2005;237: 159-169.
32. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phasecontrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991;156:307-312.
33. Vogl TJ, Steiner S, Hammerstingl R, et al. MRT of the liver in Wilson's disease [in German]. Rofo 1994;160:40-45.
34. Ryman BE. The glycogen storage diseases. J Clin Pathol Suppl (R Coll Pathol) 1974;8:106-121.
35. Abenoza P, Sibley RK. Farber's disease: a fine structural study. Ultrastruct Pathol 1987;11:397-403.
36. Beck M. Mucopolysaccharidosis: nosology, clinical aspects, therapeutic approaches [in German]. Monatsschr Kinderheilkd 1991;139:120-127.
37. Lorigan JG, Charnsangavej C, Carrasco CH, Richli WR, Wallace S. Atrophy with compensatory hypertrophy of the liver in hepatic neoplasms: radiographic findings. AJR Am J Roentgenol 1988; 150:1291-1295.
38. Mathieu D, Vasile N, Menu Y, Van Beers B, Lorphelin JM, Pringot J. Budd-Chiari syndrome: dynamic CT. Radiology 1987;165:409-413.
39. Kim BS, Kim TK, Kim JS, et al. Hepatic venous congestion after living donor liver transplantation with right lobe graft: two-phase CT findings. Radiology 2004;232:173-180.
40. Ishigami K, Stolpen AH, Al-Kass FM, et al. Diagnostic value of gadolinium-enhanced 3D magnetic resonance angiography in patients with suspected hepatic arterial complications after liver transplantation. J Comput Assist Tomogr 2005; 29:464-471.
41. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003;79:18-24.
42. Willinek WA, Hadizadeh D, von Falkenhausen M, et al. Magnetic resonance (MR) imaging and MR angiography for evaluation and follow-up of hepatic artery banding in patients with hepatic involvement of hereditary hemorrhagic telangiectasia. Abdom Imaging 2006;31:694-700.
43. Giovine S, Pinto A, Crispano S, Lassandro F, Romano L. Retrospective study of 23 cases of hepatic infarction: CT findings and pathological correlations. Radiol Med 2006;111:11-21.
44. Smith GS, Birnbaum BA, Jacobs JE. Hepatic infarction secondary to arterial insufficiency in native livers: CT findings in 10 patients. Radiology 1998; 208:223-229.
45. Kawamoto S, Soyer PA, Fishman EK, Bluemke DA. Nonneoplastic liver disease: evaluation with CT and MR imaging. RadioGraphics 1998;18: 827-848.
46. Proujansky R, Vinton N. Acute hepatitis. Adolesc Med 1995;6:437-446.
47. Thanos L, Zormpala A, Brountzos E, Nikita A, Kelekis D. Nodular hepatic and splenic sarcoidosis in a patient with normal chest radiograph. Eur J Radiol 2002;41:10-11.
48. Sakai T, Maeda M, Takabatake M, et al. MR imaging of hepatosplenic sarcoidosis. Radiat Med 1995; 13:39-41.
49. Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR Am J Roentgenol 1997;169: 1311-1316.
50. Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol 1999;106: 697-701.